Transfusion-transmissible infections monitoring system (ttims) base plus three option year contract
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40125C00074
- Awardee
-
Vitalant UEI GKT4L2JZJ622
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,406,892
Award facts
- Contract value 24% obligated
-
- $2,406,892.00 Current, with exercised options
- $9,993,424.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,406,892 | |
| Funding Only Action | $2,406,892 | |
| Original award | $2,406,892 |
About this award
This is a firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Vitalant, a non-profit organization headquartered in Scottsdale, Arizona. The contract, titled "TRANSFUSION-TRANSMISSIBLE INFECTIONS MONITORING SYSTEM (TTIMS) BASE PLUS THREE OPTION YEAR CONTRACT," has a ceiling value of $9,993,424.00 and an ultimate completion date of September 24, 2029. The contract is not set aside for any specific business type. Vitalant, through its research division Vitalant Research Institute (VRI), specializes in blood collection, processing, testing, research, and specialized medical services for federal agencies. This contract supports the FDA's requirements for the Transfusion-Transmissible Infections Monitoring System (TTIMS) program, which focuses on monitoring and addressing infectious disease risks associated with blood transfusions.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The American National Red Cross | $850,353 | |
| Oneblood, Inc. | $278,887 |
Quick answers
Who was awarded contract 75F40125C00074?
75F40125C00074 was awarded to Vitalant by Food and Drug Administration (Department of Health and Human Services) on September 8, 2025.
How much is contract 75F40125C00074 worth?
The government has obligated $2,406,892 on 75F40125C00074. Its potential value, with all options, is $9,993,424.
Was contract 75F40125C00074 competed?
The extent of competition for 75F40125C00074 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award